1-3 of 3
Shuhei Koide
Close
Sort by
Journal Articles

DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes

Clinical Trials & Observations
Kensuke Kayamori, Yurie Nagai, Cheng Zhong, Satoshi Kaito, Daisuke Shinoda, Shuhei Koide, Wakako Kuribayashi, Motohiko Oshima, Yaeko Nakajima-Takagi, Masayuki Yamashita, Naoya Mimura, Hans Jiro Becker, Kiyoko Izawa, Satoshi Yamazaki, Satoshi Iwano, Atsushi Miyawaki, Ryoji Ito, Kaoru Tohyama, William Lennox, Josephine Sheedy, Marla Weetall, Emiko Sakaida, Koutaro Yokote, Atsushi Iwama
Journal: Blood Advances
Blood Adv (2021) 5 (2): 438–450.
https://doi.org/10.1182/bloodadvances.2020001461
Published: 2021
Includes: Supplemental data
Journal Articles

Induction of blood-circulating bile acids supports recovery from myelosuppressive chemotherapy

Clinical Trials & Observations
Valgardur Sigurdsson, Youichi Haga, Hajime Takei, Els Mansell, Chizuko Okamatsu-Haga, Mitsuyoshi Suzuki, Visnja Radulovic, Mark van der Garde, Shuhei Koide, Svetlana Soboleva, Mats Gåfvels, Hiroshi Nittono, Akira Ohara, Kenichi Miharada
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1833–1843.
https://doi.org/10.1182/bloodadvances.2019000133
Published: 2020
Includes: Supplemental data
Journal Articles

Hmga2 collaborates with JAK2 V617F in the development of myeloproliferative neoplasms

Koki Ueda, Kazuhiko Ikeda, Takayuki Ikezoe, Kayo Harada-Shirado, Kazuei Ogawa, Yuko Hashimoto, Takahiro Sano, Hiroshi Ohkawara, Satoshi Kimura, Akiko Shichishima-Nakamura, Yuichi Nakamura, Yayoi Shikama, Tsutomu Mori, Philip J. Mason, Monica Bessler, Soji Morishita, Norio Komatsu, Kotaro Shide, Kazuya Shimoda, Shuhei Koide, Kazumasa Aoyama, Motohiko Oshima, Atsushi Iwama, Yasuchika Takeishi
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1001–1015.
https://doi.org/10.1182/bloodadvances.2017004457
Published: 2017
Includes: Supplemental data